Aβ-PET病理蓄积指数的推导及其评估Aβ负荷的效用
该指数与SUVR高度相关,在区分Aβ阳性与阴性参与者时,其诊断性能与SUVR相当,且无需定义感兴趣区或使用MRI。
要点
- Aβ蓄积指数与SUVR高度相关(R²范围0.916-0.951)。
- Aβ指数区分Aβ阳性和阴性的AUC为0.820-0.991,与SUVR相当。
- Aβ指数无需ROI或MRI,更易于临床实施和跨示踪剂比较。
核心结论
- 提出的Aβ蓄积指数与SUVR紧密相关,且无需定义感兴趣区或使用MRI,可能更易于临床实施并促进不同Aβ-PET示踪剂结果的比较。
主要发现
- Aβ指数与SUVR的R²在BioFINDER为0.951,ADNI为0.943,终末期研究为0.916。
- 检测异常视觉读片的AUC为0.979至0.991,检测异常CSF Aβ42/Aβ40的AUC为0.961至0.966,检测异常Aβ组织病理的AUC为0.820至0.823。
- Aβ指数和SUVR在基于抗Aβ 4G8抗体的死后Aβ分期上分布相似。
- 与仅使用视觉读片的模型相比,加入Aβ指数可显著提高检测异常Aβ组织病理的AUC并降低Akaike信息准则。
临床怎么用
- Aβ蓄积指数可在不依赖ROI和MRI的情况下定量评估Aβ负荷,便于临床推广和不同示踪剂间的结果比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate a novel β-amyloid (Aβ)-PET-based quantitative measure (Aβ accumulation index [Aβ index]), including the assessment of its ability to discriminate between participants based on Aβ status using visual read, CSF Aβ42/Aβ40, and post-mortem neuritic plaque burden as standards of truth. METHODS: One thousand one hundred twenty-one participants (with and without cognitive impairment) were scanned with Aβ-PET: Swedish BioFINDER, n = 392, [18F]flutemetamol; Alzheimer's Disease Neuroimaging Initiative (ADNI), n = 692, [18F]florbetapir; and a phase 3 end-of-life study, n = 100, [18F]flutemetamol. The relationships between Aβ index and standardized uptake values ratios (SUVR) from Aβ-PET were assessed. The diagnostic performances of Aβ index and SUVR were compared with visual reads, CSF Aβ42/Aβ40, and Aβ histopathology used as reference standards. RESULTS: Strong associations were observed between Aβ index and SUVR (R 2: BioFINDER 0.951, ADNI 0.943, end-of-life, 0.916). Both measures performed equally well in differentiating Aβ-positive from Aβ-negative participants, with areas under the curve (AUCs) of 0.979 to 0.991 to detect abnormal visual reads, AUCs of 0.961 to 0.966 to detect abnormal CSF Aβ42/Aβ40, and AUCs of 0.820 to 0.823 to detect abnormal Aβ histopathology. Both measures also showed a similar distribution across postmortem-based Aβ phases (based on anti-Aβ 4G8 antibodies). Compared to models using visual read alone, the addition of the Aβ index resulted in a significant increase in AUC and a decrease in Akaike information criterion to detect abnormal Aβ histopathology. CONCLUSION: The proposed Aβ index showed a tight association to SUVR and carries an advantage over the latter in that it does not require the definition of regions of interest or the use of MRI. Aβ index may thus prove simpler to implement in clinical settings and may also facilitate the comparison of findings using different Aβ-PET tracers. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that the Aβ accumulation index accurately differentiates Aβ-positive from Aβ-negative participants compared to Aβ-PET visual reads, CSF Aβ42/Aβ40, and Aβ histopathology.
引用
- Leuzy A, Lilja J, Buckley CJ, et al. Derivation and utility of an Aβ-PET pathology accumulation index to estimate Aβ load. Neurology. 2020. PMID: 33077542. doi:10.1212/WNL.0000000000011031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。